Elin Mignérus new CEO of Polymer Factory Sweden AB
As of today, April 1, 2021, Elin Mignérus is taking over as CEO of Polymer Factory Sweden AB. Prior to joining Polymer Factory, Elin Mignérus was most recently the CEO of CathPrint AB, a company that designs and manufactures technology for use in advanced catheters. In 2020, she was named one of Sweden’s most inspiring entrepreneurs by Företagarna and ALMI. Mignérus has an M.Sc. in Biomedical Engineering and Technopreneurship from KTH Royal Institute of Technology and the National University of Singapore.
Polymer Factory has emerged out of many years of cutting-edge research in the field of dendritic materials and has evolved into a leader in advanced dendritic nanotechnologies. Our capitalization through IPO will enable us to invest in our business and sales organization, and more actively pursue tailored and royalty-based agreements with large multinational corporates. We are confident that the business has potential to grow tremendously and attract more customers from a wide range of technologically demanding sectors, such as MedTech and BioTech. We are very excited about welcoming new investors as we now work towards realizing Polymer Factory’s huge underlying values.
CEO Elin Mignérus comments:
“I am happy and proud to be entrusted by the board of directors to take over the leadership of Polymer Factory Sweden AB as the company goes public and enters its next phase. The knowledge that exists in the company, stemming from many years of cutting-edge research and development, is deeply impressing and gives a strong foundation to build on. I very much look forward to leading us on a journey of continued development and growth together with Polymer Factory’s dedicated team.”
CTO (Former CEO) Michael Malkoch comments:
“Polymer Factory has a unique nanotechnological platform that under my guidance, as the CEO, was transformed over the last years to attractive products. Polymer Factory is now ready to scale-up its business activities taking strength from the plethora of buying customers that historically have been in contact with the Company. Consequently, I will take a more natural role as the CTO of the company and in parallel ensure smooth transfer of knowledge to our new CEO Elin Mignérus. With Elin onboard as the CEO, I and the rest of Polymer Factory are excited about the future Factory. I am confident that we, as a collective, can deliver to the market what is envisaged from our cutting-edge dendritic nanomaterials.”
About Polymer Factory
Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors and CEO have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.
For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com
Polymer Factory is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.